CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
Blephapad Combo +1 morecombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03301844
NCT03301844N/ACompleted
CompareCT.gov

Randomized, Controlled Study With a Closed Sequential Design to Compare the Efficacy, Safety and Patient Satisfaction of Blephapad Combo vs. Standard Treatment for Eyelid Cleansing in Patients Affected by Bilateral Posterior Blepharitis.

NTC srl·interventional·Posted Oct 4, 2017·Updated Dec 19, 2019

In Brief

A clinical study evaluating Blephapad Combo and Standard treatment for Bilateral Blepharitis (Disorder). Completed, enrolled 19 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the efficacy of, and patient satisfaction with Blephapad Combo in the treatment of posterior blepharitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBilateral Blepharitis (Disorder)
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 4, 2017
Enrollment StartMay 15, 2017
Primary CompletionFeb 9, 2018
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 8.7 years ago

Interventions

Blephapad Combocombination

Blephapad Combo is used to cleanse, soften, sooth and decongest inflamed eyelids and cilia. The combo also presents an applicator with a heatable tablet that is applied to the eyelid in order to clean and open occluded Meibomian glands, thereby allowing the production of lipids necessary for a healthy tear film. The heatable tablet is to be used prior to cleansing with Blephapad wipes.

Standard treatmentother

Standard treatment, twice daily for one month, consisting in eyelid hygiene using wet, warm gauze.